Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
4,662
-47
-1% -$2.17K 0.02% 448
2026
Q1
$208K Buy
4,709
+205
+5% +$9.54K 0.02% 434
2025
Q4
$209K Sell
4,504
-766
-15% -$35K 0.02% 411
2025
Q3
$243K Sell
5,270
-86
-2% -$3.78K 0.02% 279
2025
Q2
$233K Buy
+5,356
New +$238K 0.02% 416

Other funds holding EXC

Armis Advisers's EXC Position: Q2 2026 in Review

Armis Advisers reduced its Exelon (EXC) stake by 1% in Q2 2026, selling an estimated $2.17K and leaving 4,662 shares worth $219K. The position accounts for 0.02% of the portfolio, ranked #448.

Armis Advisers first reported a position in EXC in Q2 2025 and has held it in 5 quarters since. The position peaked at $243K in Q3 2025. 209 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Armis Advisers held 4,662 shares of Exelon worth $219K as of Q2 2026.
  • Armis Advisers sold 47 Exelon shares in Q2 2026, an estimated $2.17K.
  • Exelon made up 0.02% of Armis Advisers's portfolio in Q2 2026, its #448 holding.
  • Armis Advisers first reported a position in Exelon in Q2 2025 and has held it in 5 quarters since.
  • Armis Advisers's Exelon position peaked at $243K in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.